Add ultrasound vendor Advanced Technology Laboratories to thelist of medical imaging vendors celebrating improved financialresults. The Bothell, WA, company said last week that revenueshad increased almost 8% for its second quarter (end-June), largelyon
Add ultrasound vendor Advanced Technology Laboratories to thelist of medical imaging vendors celebrating improved financialresults. The Bothell, WA, company said last week that revenueshad increased almost 8% for its second quarter (end-June), largelyon the synergies achieved from its merger with Interspec lastyear (SCAN 2/16/94).
ATL had revenues of $91.3 million for the quarter, compared torevenues of $84.8 million in the same period the year before.ATL's net income for the most recent quarter was $836,000, comparedto a loss of $9.9 million in the second quarter of 1994. Thatfigure included costs related to ATL's acquisition of Interspec.
With the results, ATL posted its first net profit since the firstquarter of 1994. The company posted operating profits in the firstquarter of 1995 and the fourth quarter of 1994, but its net resultswere dragged down by nonrecurring charges related to the Interspecpurchase.
ATL's improvement is due to the integration of its distributionchannels with Interspec's mid-range product line, according toATL spokesperson Anne Bugge. ATL's premium HDI 3000 scanner isshowing momentum worldwide, Bugge said, and the company has shippedwell over 300 systems.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.